BioCentury
ARTICLE | Company News

LeukoDx, Trillium Diagnostics deal

January 25, 2010 8:00 AM UTC

The companies signed a memorandum of understanding under which LeukoDx will receive exclusive, worldwide rights to Trillium's patent and technology covering the quantification of Fc gamma receptor I ...